Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma

The most common malignant central nervous system tumor is glioblastoma multiforme (GBM). Cytokine-induced killer (CIK) cell therapy is a promising type of adoptive cell immunotherapy for various cancers. We previously conducted a randomized clinical trial on CIK cell therapy in patients with GBM. Th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Myung-Hoon Han, Jae Min Kim, Jin Hwan Cheong, Je Il Ryu, Yu Deok Won, Gun He Nam, Choong Hyun Kim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-04-01
coleção:	Frontiers in Oncology
Assuntos:	glioblastoma multiforme cytokine-induced killer cell (CIK) immunotherapy adoptive cell transfer overall survival
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.851628/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!